Pleiotropic effects of statins: New evidences
Yıl: 2021 Cilt: 49 Sayı: 7 Sayfa Aralığı: 533 - 535 Metin Dili: İngilizce DOI: 10.5543/tkda.2021.21211 İndeks Tarihi: 29-01-2022
Pleiotropic effects of statins: New evidences
Öz: -
Anahtar Kelime: Statinlerin pleitropik etkileri: Yeni kanıtlar
Öz: -
Anahtar Kelime: Belge Türü: Makale Makale Türü: Editoryal Erişim Türü: Erişime Açık
- 1. Oesterle A, Laufs U, Liao JK. Pleiotropic effects of statins on the cardiovascular system. Circ Res 2017;120:229-43. [Crossref]
- 2. Murphy C, Deplazes E, Cranfield CG, Garcia A. The role of structure and biophysical properties in the pleiotropic effects of statins. Int J Mol Sci 2020;21:8745. [Crossref]
- 3. Zhang Q, Dong J, Yu Z. Pleiotropic use of Statins as non-lipid-lowering drugs. Int J Biol Sci 2020;16:2704-11. [Crossref]
- 4. Olszewska-Parasiewicz J, Szarpak Ł, Rogula S, Gąsecka A, Szymańska U, Kwiatkowska M, et al. Statins in COVID-19 therapy. Life (Basel) 2021;11(6):565. [Crossref]
- 5. Raju MG, Pachika A, Punnam SR, Gardiner JC, Shishehbor MH, Kapadia SR, et al. Statin therapy in the reduction of cardiovascular events in patients undergoing intermediate risk noncardiac, nonvascular surgery. Clin Cardiol 2013;36:456-61. [Crossref]
- 6. Patti G, Chello M, Candura D, Pasceri V, D’Ambrosio A, Covino E, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for reduction of myocardial Dysrhythmia after cardiac surgery) study. Circulation 2006;114:1455-61. [Crossref]
- 7. Elgendy IY, Mahmoud A, Huo T, Beaver TM, Bavry AA. Meta-analysis of 12 trials evaluating the effects of statins on decreasing atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2015;115:1523-8. [Crossref]
- 8. Zheng Z, Jayaram R, Jiang L, Emberson J, Zhao Y, Li Q, et al. Perioperative Rosuvastatin in cardiac surgery. N Engl J Med 2016;374:1744-53. [Crossref]
- 9. Siskos D, Tziomalos K. The role of statins in the management of patients undergoing coronary artery bypass grafting. Diseases 2018;6:102. [Crossref]
- 10. Galyfos G, Sianou A, Filis K. Pleiotropic effects of statins in the perioperative setting. Ann Card Anaesth 2017;20:S43-8. [Crossref]
- 11. Nomani H, Mohammadpour AH, Reiner Ž, Jamialahmadi T, Sahebkar A. Statin therapy in post-operative atrial fibrillation: focus on the anti-ınflammatory effects. J Cardiovasc Dev Dis 2021;8:24. [Crossref]
- 12. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, Hert SD, et al. 2014 ESC/ESA Guidelines on non cardiac surgery: Cardiovascular assessment and management: The Joint Task Force on non cardiac surgery: Cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014;35:2383-431. [Crossref]
- 13. Auguadro C, Manfredi M, Scalise F, Mortara A, Specchia G. Protective role of chronic statin therapy in reducing myocardial damage during percutaneous coronary intervention. J Cardiovasc Med (Hagerstown) 2006;7:416-21. [Crossref]
- 14. He GX, Tan W. High-dose atorvastatin pretreatment could diminishes microvascular impairment in patients undergoing elective percutaneous coronary intervention. J Geriatr Cardiol 2013;10:355-60.
- 15. Ari H, Emlek N, Ari S, Cosar S, Doganay K, Aydin C, et al. The effect of high dose cilostazol and rosuvastatin on periprocedural myocardial ınjury in patients with elective percutaneous coronary ıntervention. Acta Cardiol Sin 2015;31:292-300.
- 16. Xiao Y, He S, Zhang Z, Feng H, Cui S, Wu J. Effect of high-dose statin pretreatment for myocardial perfusion in patients receiving percutaneous coronary ıntervention (PCI): A meta-analysis of 15 randomized studies. Med Sci Monit 2018;24:9166-76. [Crossref]
- 17. Koçak A, Ünlü S, Gökalp G, Yılmaz NS, Gülbahar Ö, Abacı A. The relationship between long term statin usage and myocardial injury related to percutaneous coronary interventions evaluated by high sensitivity troponins. Turk Kardiyol Dern Ars 2021;49:536-44.
| APA | okyay k (2021). Pleiotropic effects of statins: New evidences. , 533 - 535. 10.5543/tkda.2021.21211 |
| Chicago | okyay kaan Pleiotropic effects of statins: New evidences. (2021): 533 - 535. 10.5543/tkda.2021.21211 |
| MLA | okyay kaan Pleiotropic effects of statins: New evidences. , 2021, ss.533 - 535. 10.5543/tkda.2021.21211 |
| AMA | okyay k Pleiotropic effects of statins: New evidences. . 2021; 533 - 535. 10.5543/tkda.2021.21211 |
| Vancouver | okyay k Pleiotropic effects of statins: New evidences. . 2021; 533 - 535. 10.5543/tkda.2021.21211 |
| IEEE | okyay k "Pleiotropic effects of statins: New evidences." , ss.533 - 535, 2021. 10.5543/tkda.2021.21211 |
| ISNAD | okyay, kaan. "Pleiotropic effects of statins: New evidences". (2021), 533-535. https://doi.org/10.5543/tkda.2021.21211 |
| APA | okyay k (2021). Pleiotropic effects of statins: New evidences. Türk Kardiyoloji Derneği Arşivi, 49(7), 533 - 535. 10.5543/tkda.2021.21211 |
| Chicago | okyay kaan Pleiotropic effects of statins: New evidences. Türk Kardiyoloji Derneği Arşivi 49, no.7 (2021): 533 - 535. 10.5543/tkda.2021.21211 |
| MLA | okyay kaan Pleiotropic effects of statins: New evidences. Türk Kardiyoloji Derneği Arşivi, vol.49, no.7, 2021, ss.533 - 535. 10.5543/tkda.2021.21211 |
| AMA | okyay k Pleiotropic effects of statins: New evidences. Türk Kardiyoloji Derneği Arşivi. 2021; 49(7): 533 - 535. 10.5543/tkda.2021.21211 |
| Vancouver | okyay k Pleiotropic effects of statins: New evidences. Türk Kardiyoloji Derneği Arşivi. 2021; 49(7): 533 - 535. 10.5543/tkda.2021.21211 |
| IEEE | okyay k "Pleiotropic effects of statins: New evidences." Türk Kardiyoloji Derneği Arşivi, 49, ss.533 - 535, 2021. 10.5543/tkda.2021.21211 |
| ISNAD | okyay, kaan. "Pleiotropic effects of statins: New evidences". Türk Kardiyoloji Derneği Arşivi 49/7 (2021), 533-535. https://doi.org/10.5543/tkda.2021.21211 |
